undamentalytics Newsletter
Sign in

Inspiremd, Inc. cash flow statement

In fiscal 2025, Inspiremd, Inc.'s operations generated −$35.1m of cash; it spent $1.7m on capital projects, leaving free cash flow of −$36.8m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Dec 20092010Dec 20102011Dec 20112012Jun 20122013Jun 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMJun 2026
Cash from operations−2−3−6−9−10−19−12−7−8−8−10−9−13−16−16−22−35−41
Depreciation and amortisation0000000000000188232280476476
Stock-based pay12101144311001224101211
Capital spending000000000000000121
Free cash flow−2−3−6−9−11−19−12−8−8−8−10−9−14−16−17−23−37−42
Free cash flow after stock pay−2−4−16−19−14−24−15−9−9−8−10−10−15−18−21−33−49−53
Share buybacks———0——————————————
Shares issued1211—2310121471661635—3811—

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: NSPR vs WOKHSDT vs NSPRNMTC vs NSPRNNOX vs NSPR

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Inspiremd, Inc.'s SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Inspiremd, Inc.